tiprankstipranks
Taysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
PremiumThe FlyTaysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
27d ago
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
PremiumThe Fly
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
27d ago
Taysha Gene Therapies falls 12% to $2.16 after filing to sell $75M shares
PremiumThe Fly
Taysha Gene Therapies falls 12% to $2.16 after filing to sell $75M shares
28d ago
Taysha announces ‘low dose cohort data’  from REVEAL trial for Rett syndrome
PremiumThe FlyTaysha announces ‘low dose cohort data’ from REVEAL trial for Rett syndrome
1M ago
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
PremiumPress Releases
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
1M ago
Taysha Gene Therapies to present clinical data from REVEAL Phase 1/2 trials
PremiumThe Fly
Taysha Gene Therapies to present clinical data from REVEAL Phase 1/2 trials
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100